Priority Criminal Justice Needs Initiative
Aug 18, 2014
An expert panel of law enforcement leaders identified promising efforts to combat the opioid crisis, including connecting people with opioid use disorder to medication-assisted treatment; building lasting partnerships to achieve community buy-in, enable information sharing, and effectively tackle challenges; and addressing community and other stakeholder concerns before high-priority harm-reduction approaches can be pursued.
Convening Police Leaders, Multidisciplinary Partners, and Researchers to Identify Promising Practices and to Inform a Research Agenda
|PDF file||1.2 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
The United States is grappling with an opioid crisis that continues to cause devastation from addiction and massive numbers of deaths from overdose. Law enforcement has a unique role in addressing this crisis because it is directly tasked with interacting with those affected by the crisis on a day-to-day basis.
On September 25 and 26, 2018, the National Institute of Justice (NIJ), supported by the RAND Corporation in partnership with the Police Executive Research Forum, hosted an event that brought together subject-matter experts to identify and prioritize promising approaches for responding to the opioid crisis. After a series of panels and discussions, participants produced 13 high-priority needs, including strategies that were perceived to be ready for immediate implementation and those with remaining challenges that should inform the research agenda. The high-priority needs reflect an assessment by the group that one primary solution to the opioid crisis will be a focus on connecting individuals with opioid use disorder (OUD) to the medications that can treat them. It will be important to pursue solutions that reduce barriers to the use of medication-assisted treatment (MAT) and expand access and funding for it. Connecting individuals with OUD to treatment will require effective collaborations among law enforcement officers, social workers, and other stakeholders. Finally, in addition to removing legal barriers, community and other stakeholder concerns will need to be addressed before high-priority harm-reduction approaches, such as safe injection sites or syringe exchanges, can be implemented.
The research described in this report was sponsored by the National Institute of Justice and conducted in the Justice Policy Program within RAND Social and Economic Well-Being.
This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.